2,043
Views
25
CrossRef citations to date
0
Altmetric
Research Paper

Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment

&
Pages 458-467 | Received 30 Jul 2014, Accepted 04 Oct 2014, Published online: 31 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rose P. Webster, Jordan A. Marckel & Andrew B. Norman. (2023) Toxicokinetics of a humanized anti-cocaine monoclonal antibody in male and female rats and lack of cross-reactivity. Human Vaccines & Immunotherapeutics 19:3.
Read now
Marco Pravetoni. (2016) Biologics to treat substance use disorders: Current status and new directions. Human Vaccines & Immunotherapeutics 12:12, pages 3005-3019.
Read now

Articles from other publishers (23)

Terence L. Kirley & Andrew B. Norman. (2024) Novel partial reduction of the humanized anti-cocaine mAb h2E2 for selective cysteine labeling. Biochemical and Biophysical Research Communications 692, pages 149362.
Crossref
Terence L. Kirley & Andrew B. Norman. (2023) Characterization and optimization of fluorescein isothiocyanate labeling of humanized h2E2 anti-cocaine mAb. Biochemistry and Biophysics Reports 35, pages 101520.
Crossref
Terence L. Kirley & Andrew B. Norman. (2022) Isothermal titration calorimetry determination of thermodynamics of binding of cocaine and its metabolites to humanized h2E2 anti-cocaine mAb. Biochemistry and Biophysics Reports 32, pages 101354.
Crossref
Terence L. Kirley & Andrew B. Norman. (2022) Critical evaluation of fluorescent dyes to evaluate the stability and ligand binding properties of an anti-cocaine mAb, h2E2. Journal of Immunological Methods 508, pages 113323.
Crossref
Terence L. Kirley, Kenneth D. Greis & Andrew B. Norman. (2022) Tyrosine nitration of a humanized anti-cocaine mAb differentially affects ligand binding of cocaine and its metabolites. Biochemistry and Biophysics Reports 30, pages 101278.
Crossref
Terence L. Kirley, Andrew B. Norman & Kenneth D. Greis. (2022) Oxidation of specific tryptophan residues inhibits high-affinity binding of cocaine and its metabolites to a humanized anticocaine mAb. Journal of Biological Chemistry 298:3, pages 101689.
Crossref
Terence L. Kirley & Andrew B. Norman. (2021) Cocaine binding to the Fab fragment of a humanized anti-cocaine mAb quantitated by dye absorption and fluorescence spectroscopy. Journal of Immunological Methods 496, pages 113103.
Crossref
Terence L. Kirley & Andrew B. Norman. (2021) Ligand binding to a humanized anti-cocaine mAb measured by dye absorption spectroscopy. Biochemical and Biophysical Research Communications 535, pages 93-98.
Crossref
Terence L. Kirley & Andrew B. Norman. (2020) Multi-domain unfolding of the Fab fragment of a humanized anti-cocaine mAb characterized by non-reducing SDS-PAGE. Biochemical and Biophysical Research Communications 533:3, pages 580-585.
Crossref
Terence L. Kirley & Andrew B. Norman. (2020) Ligand binding to a humanized anti-cocaine mAb detected by non-reducing SDS-PAGE. Biochemistry and Biophysics Reports 23, pages 100795.
Crossref
Terence L. Kirley, Andrew B. Norman & Hanna N. Wetzel. (2020) A novel differential scanning fluorimetry analysis of a humanized anti-cocaine mAb and its ligand binding characteristics. Journal of Immunological Methods 476, pages 112676.
Crossref
Kemin Tan, Min Zhou, Angela J. Ahrendt, Norma E. C. Duke, Nassif Tabaja, William J. Ball, Terence L. Kirley, Andrew B. Norman, Andrzej Joachimiak, Marianne Schiffer, Rosemarie Wilton & P. Raj Pokkuluri. (2019) Structural analysis of free and liganded forms of the Fab fragment of a high-affinity anti-cocaine antibody, h2E2. Acta Crystallographica Section F Structural Biology Communications 75:11, pages 697-706.
Crossref
Terence L. Kirley, Kenneth D. Greis & Andrew B. Norman. (2018) Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE. Biochemistry and Biophysics Reports 16, pages 138-144.
Crossref
M. A. Myagkova & V. S. Morozova. (2018) Vaccines for substance abuse treatment: new approaches in the immunotherapy of addictions. Russian Chemical Bulletin 67:10, pages 1781-1793.
Crossref
Terence L. Kirley & Andrew B. Norman. (2018) Unfolding of IgG domains detected by non-reducing SDS-PAGE. Biochemical and Biophysical Research Communications 503:2, pages 944-949.
Crossref
Hanna N. Wetzel, Tongli Zhang & Andrew B. Norman. (2017) A mathematical model of a recombinant humanized anti-cocaine monoclonal antibody's effects on cocaine pharmacokinetics in mice. Life Sciences 184, pages 81-86.
Crossref
Hanna N. Wetzel, Cinder Cohen, Andrew B. Norman & Rose P. Webster. (2017) A novel Python program for implementation of quality control in the ELISA. Journal of Immunological Methods 448, pages 80-84.
Crossref
Hanna N. Wetzel, Rose P. Webster, Fatima O. Saeed, Terence L. Kirley, William J. Ball & Andrew B. Norman. (2017) Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate. Biochemical and Biophysical Research Communications 487:3, pages 690-694.
Crossref
Sasa Chu, Xuhui Zhu, Na You, Wei Zhang, Feng Zheng, Binggang Cai, Tingting Zhou, Yiwen Wang, Qiannan Sun, Zhiguo Yang, Xin Zhang, Changjun Wang, Shinan Nie, Jin Zhu & Maorong Wang. (2016) The Fab Fragment of a Human Anti-Siglec-9 Monoclonal Antibody Suppresses LPS-Induced Inflammatory Responses in Human Macrophages. Frontiers in Immunology 7.
Crossref
Hanna N. Wetzel, Vladimir L. Tsibulsky & Andrew B. Norman. (2016) The effects of a repeated dose of a recombinant humanized anti-cocaine monoclonal antibody on cocaine self-administration in rats. Drug and Alcohol Dependence 168, pages 287-292.
Crossref
Terence L. Kirley, Kenneth D. Greis & Andrew B. Norman. (2016) Selective disulfide reduction for labeling and enhancement of Fab antibody fragments. Biochemical and Biophysical Research Communications 480:4, pages 752-757.
Crossref
Terence L. Kirley, Kenneth D. Greis & Andrew B. Norman. (2016) Structural characterization of expressed monoclonal antibodies by single sample mass spectral analysis after IdeS proteolysis. Biochemical and Biophysical Research Communications 477:3, pages 363-368.
Crossref
Hanna N. Wetzel, William J. Ball & Andrew B. Norman. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders 109 117 .